Corrigendum to “Mitochondrial DNA has a pro-inflammatory role in AMD” [Biochim. Biophys. Acta 1853 (2015) 2897-2906, (S0167488915002815), (10.1016/j.bbamcr.2015.08.012)];Mitochondrial DNA has a pro-inflammatory role in AMD

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 11, 2015, Pages 2897-2906

  Dib, Bernard ^a   Lin, Haijiang ^a   Maidana, Daniel E ^a   Tian, Bo ^a   Miller, John B ^a   Bouzika, Peggy ^a   Miller, Joan W ^a   Vavvas, Demetrios G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Age related macular degeneration; Inflammation; Mitochondrial DNA; NLRP3 inflammasome; Retinal pigment epithelium

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CRYOPYRIN; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; MITOCHONDRIAL DNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; CARRIER PROTEIN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INFLAMMASOME; NLRP3 PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE COURSE; GENE; HUMAN; HUMAN CELL; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; STIMULATOR OF INTERFERON GENE; CELL LINE; MACULAR DEGENERATION; METABOLISM; PATHOLOGY;

CARRIER PROTEINS; CELL LINE; DNA, MITOCHONDRIAL; HUMANS; INFLAMMASOMES; INTERLEUKIN-6; INTERLEUKIN-8; MACULAR DEGENERATION; OXIDATIVE STRESS;

EID: 84940902284     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2024.119790     Document Type: Erratum

References (84)

1. Reeve A.K., Krishnan K.J., Turnbull D. Mitochondrial DNA mutations in disease, aging, and neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:21-29. 10.1196/annals.1427.016.
2. Currais A. Ageing and inflammation - a central role for mitochondria in brain health and disease. Ageing Res. Rev. 2015, 1-13. 10.1016/j.arr.2015.02.001.
3. Blasiak J., Glowacki S., Kauppinen A., Kaarniranta K. Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration. Int. J. Mol. Sci. 2013, 14:2996-3010. 10.3390/ijms14022996.
4. Jarrett S.G., Lewin A.S., Boulton M.E. The importance of mitochondria in age-related and inherited eye disorders. Ophthalmic Res. 2010, 44:179-190. 10.1159/000316480.
5. Karunadharma P.P., Nordgaard C.L., Olsen T.W., Ferrington D.A. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2010, 51(11):5470-5479. 10.1167/iovs.10-5429.
6. Lin H., Xu H., Liang F.-Q., et al. Mitochondrial DNA damage and repair in RPE associated with aging and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52(6):3521-3529. 10.1167/iovs.10-6163.
7. Terluk M.R., Kapphahn R.J., Soukup L.M., et al. Investigating mitochondria as a target for treating age-related macular degeneration. J. Neurosci. 2015, 35(18):7304-7311. 10.1523/JNEUROSCI.0190-15.2015.
8. Feher J., Kovacs I., Artico M., Cavallotti C., Papale A., Balacco Gabrieli C. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging 2006, 27:983-993. 10.1016/j.neurobiolaging.2005.05.012.
9. Krysko D.V., Agostinis P., Krysko O., et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 2011, 32(4):157-164. 10.1016/j.it.2011.01.005.
10. Collins L.V., Hajizadeh S., Holme E., Jonsson I.-M., Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. Leukoc. Biol. 2004, 75(6):995-1000. 10.1189/jlb.0703328.
11. Oka T., Hikoso S., Yamaguchi O., et al. Corrigendum: mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 490(7397):292. 10.1038/nature11515.
12. Zhang Q., Raoof M., Chen Y., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464(7285):104-107. 10.1038/nature08780.
13. Zhang J.Z., Liu Z., Liu J., Ren J.X., Sun T.S. Mitochondrial DNA induces inflammation and increases TLR9/NF-κB expression in lung tissue. Int. J. Mol. Med. 2014, 33:817-824. 10.3892/ijmm.2014.1650.
14. Puskarich M.A., Shapiro N.I., Trzeciak S., Kline J.A., Jones A.E. Plasma levels of mitochondrial DNA in patients presenting to the emergency department with sepsis. Shock 2012, 38(4):337-340. 10.1097/SHK.0b013e318266a169.
15. Pinti M., Cevenini E., Nasi M., et al. Circulating mitochondrial DNA increases with age and is a familiar trait: implications for "inflamm-aging". Eur. J. Immunol. 2014, 44(5):1552-1562. 10.1002/eji.201343921.
16. Marques P.E., Amaral S.S., Pires D.A., et al. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 2012, 56(5):1971-1982. 10.1002/hep.25801.
17. Cao H., Ye H., Sun Z., et al. Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients. PLoS One 2014, 9:e113179. 10.1371/journal.pone.0113179.
18. Mathew A. Lindsley T a., Sheridan A, et al. Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. J. Alzheimer's Dis. 2012, 30:617-627. 10.3233/JAD-2012-120145.
19. Wilkins H.M., Carl S.M., Weber S.G., et al. Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. J. Alzheimers Dis. 2014, 10.3233/JAD-142334.
20. Pazmandi K., Agod Z., Kumar B.V., et al. Oxidative modification enhances the immunostimulatory effects of extracellular mitochondrial DNA on plasmacytoid dendritic cells. Free Radic. Biol. Med. 2014, 77:281-290. 10.1016/j.freeradbiomed.2014.09.028.
21. Tsai Y.-Y., Lin J.-M., Wan L., et al. Interleukin gene polymorphisms in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49(2):693-698. 10.1167/iovs.07-0125.
22. Seddon J.M., George S., Rosner B., Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol. 2005, 123(6):774-782. 10.1001/archopht.123.6.774.
23. Ricci F., Staurenghi G., Lepre T., et al. Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study. PLoS One 2013, 8(6):e66978. 10.1371/journal.pone.0066978.
24. Klein R., Myers C.E., Cruickshanks K.J., et al. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol. 2014, 132(4):446-455. 10.1001/jamaophthalmol.2013.7671.
25. Goverdhan S.V., Ennis S., Hannan S.R., et al. Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration. Br. J. Ophthalmol. 2008, 92(4):537-540. 10.1136/bjo.2007.123190.
26. Izumi-Nagai K., Nagai N., Ozawa Y., et al. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT) promotes choroidal neovascularization. Am. J. Pathol. 2007, 170(6):2149-2158. 10.2353/ajpath.2007.061018.
27. Miao H., Tao Y., Li X. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol. Vis. 2012, 18:574-580. (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3298419&tool=pmcentrez&rendertype=abstract. Accessed February 18, 2015).
28. Roh M.I., Kim H.S., Song J.H., Lim J.B., Koh H.J., Kwon O.W. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with and after bevacizumab treatment. Retina 2009, 29(4):523-529. 10.1097/IAE.0b013e318195cb15.
29. Nakahira K., Haspel J.A., Rathinam V.A.K., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 2011, 12(3):222-230. 10.1038/ni.1980.
30. Shimada K., Crother T.R., Karlin J., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36(3):401-414. 10.1016/j.immuni.2012.01.009.
31. Marneros A. NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration. Cell Rep. 2013, 4(5):945-958. 10.1016/j.celrep.2013.08.002.
32. Tarallo V., Hirano Y., Gelfand B.D., et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012, 149:847-859. 10.1016/j.cell.2012.03.036.
33. Doyle S.L., Campbell M., Ozaki E., et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat. Med. 2012, 18(5):791-798. 10.1038/nm.2717.
34. Lamkanfi M., Dixit V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157(5):1013-1022. 10.1016/j.cell.2014.04.007.
35. Ambati J., Fowler B.J. Mechanisms of age-related macular degeneration. Neuron 2012, 75:26-39. 10.1016/j.neuron.2012.06.018.
36. Paludan S., Bowie A. Immune sensing of DNA. Immunity 2013, 38(5):870-880. 10.1016/j.immuni.2013.05.004.
37. Bannwarth S., Procaccio V., Paquis-Flucklinger V. Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific surveyor nuclease. Nat. Protoc. 2006, 1(4):2037-2047. 10.1038/nprot.2006.318.
38. Mitter S.K., Song C., Qi X., et al. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy 2014, 10(February 2015):1989-2005. 10.4161/auto.36184.
39. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976, 60(5):324-341. 10.1136/bjo.60.5.324.
40. Garg A.D., Nowis D., Golab J., Vandenabeele P., Krysko D.V., Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim. Biophys. Acta, Rev. Cancer 2010, 1805(1):53-71. 10.1016/j.bbcan.2009.08.003.
41. Udar N., Atilano S.R., Memarzadeh M., et al. Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2009, 50(6):2966-2974. 10.1167/iovs.08-2646.
42. Burdette D.L., Vance R.E. STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 2013, 14(1):19-26. 10.1038/ni.2491.
43. Abe T., Barber G.N. Cytosolic-DNA-Mediated, STING-Dependent Proinflammatory Gene Induction Necessitates Canonical NF-κB Activation through TBK1. J. Virol. 2014, 88(10):5328-5341. 10.1128/JVI.00037-14.
44. Blaauboer S.M., Gabrielle V.D., Jin L. MPYS/STING-mediated TNF-, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-Di-guanosine-monophosphate in vivo. J. Immunol. 2013, 192:492-502. 10.4049/jimmunol.1301812.
45. Bauernfeind F.G., Horvath G., Stutz A., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183(2):787-791. 10.4049/jimmunol.0901363.
46. Qiao Y., Wang P., Qi J., Zhang L., Gao C. TLR-induced NF-kB activation regulates NLRP3 expression in murine macrophages. FEBS Lett. 2012, 586(7):1022-1026. 10.1016/j.febslet.2012.02.045.
47. Nordgaard C.L., Berg K.M., Kapphahn R.J., et al. Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47(3):815-822. 10.1167/iovs.05-0976.
48. Kenney M.C., Chwa M., Atilano S.R., et al. Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions. Hum. Mol. Genet. 2014, 23(13):3537-3551. 10.1093/hmg/ddu065.
49. Kenney M.C., Chwa M., Atilano S.R., et al. Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One 2013, 8(1):e54339. 10.1371/journal.pone.0054339.
50. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308(5720):385-389. 10.1126/science.1109557.
51. Okamoto H., Umeda S., Obazawa M., et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol. Vis. 2006, 12:156-158. (http://www.ncbi.nlm.nih.gov/pubmed/16541016. Accessed August 8, 2015).
52. Yanagisawa S., Kondo N., Miki A., et al. A common complement C3 variant is associated with protection against wet age-related macular degeneration in a Japanese population. PLoS One 2011, 6(12):e28847. 10.1371/journal.pone.0028847.
53. Yoshida T., DeWan A., Zhang H., et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol. Vis. 2007, 13:545-548. (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2652018&tool=pmcentrez&rendertype=abstract. Accessed August 8, 2015).
54. Fu L., Garland D., Yang Z., et al. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum. Mol. Genet. 2007, 16(20):2411-2422. 10.1093/hmg/ddm198.
55. Marmorstein L.Y., Munier F.L., Arsenijevic Y., et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(20):13067-13072. 10.1073/pnas.202491599.
56. Stone E.M., Lotery A.J., Munier F.L., et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat. Genet. 1999, 22(2):199-202. 10.1038/9722.
57. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(20):7227-7232. 10.1073/pnas.0501536102.
58. Patel M., Chan C.-C. Immunopathological aspects of age-related macular degeneration. Semin. Immunopathol. 2008, 30(2):97-110. 10.1007/s00281-008-0112-9.
59. Cohen T., Nahari D., Cerem L.W., Neufeld G., Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 1996, 271(2):736-741. (http://www.ncbi.nlm.nih.gov/pubmed/8557680. Accessed February 26, 2015).
60. Heidemann J., Ogawa H., Dwinell M.B., et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 2003, 278(10):8508-8515. 10.1074/jbc.M208231200.
61. Martin D., Galisteo R., Gutkind J.S. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J. Biol. Chem. 2009, 284(10):6038-6042. 10.1074/jbc.C800207200.
62. Tzeng H.-E., Tsai C.-H., Chang Z.-L., et al. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma. Biochem. Pharmacol. 2013, 85(4):531-540. 10.1016/j.bcp.2012.11.021.
63. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45(2):115-134. http://www.ncbi.nlm.nih.gov/pubmed/11033038. Accessed February 24, 2015.
64. Kimura K., Isashiki Y., Sonoda S., Kakiuchi-Matsumoto T., Ohba N. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J. Ophthalmol. 2000, 130(6):769-773. (http://www.ncbi.nlm.nih.gov/pubmed/11124296. Accessed July 22, 2015).
65. Kan M., Liu F., Weng X., et al. Association study of newly identified age-related macular degeneration susceptible loci SOD2, MBP, and C8orf42 in Han Chinese population. Diagn. Pathol. 2014, 9:73. 10.1186/1746-1596-9-73.
66. Muller F. The nature and mechanism of superoxide production by the electron transport chain: its relevance to aging. J. Am. Aging Assoc. 2000, 23(4):227-253. 10.1007/s11357-000-0022-9.
67. Leifer C.A., Kennedy M.N., Mazzoni A., Lee C., Kruhlak M.J., Segal D.M. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 2004, 173(2):1179-1183. (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2757936&tool=pmcentrez&rendertype=abstract. Accessed February 26, 2015).
68. Latz E., Schoenemeyer A., Visintin A., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 2004, 5(2):190-198. 10.1038/ni1028.
69. Ebihara N., Chen L., Tokura T., Ushio H., Iwatsu M., Murakami A. Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells. Ophthalmic Res. 2007, 39:155-163. 10.1159/000103235.
70. Ries M., Schuster P., Thomann S., Donhauser N., Vollmer J., Schmidt B. Identification of novel oligonucleotides from mitochondrial DNA that spontaneously induce plasmacytoid dendritic cell activation. J. Leukoc. Biol. 2013, 94(July):123-135. 10.1189/jlb.0612278.
71. Izumi-Nagai K., Nagai N., Ohgami K., et al. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler. Thromb. Vasc. Biol. 2007, 27(12):2555-2562. 10.1161/ATVBAHA.107.151431.
72. Izumi-Nagai K., Nagai N., Ohgami K., et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest. Ophthalmol. Vis. Sci. 2008, 49(4):1679-1685. 10.1167/iovs.07-1426.
73. Liu X.-C., Liu X.-F., Jian C.-X., Li C.-J., He S.-Z. IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells. Inflammation 2012, 35(2):776-784. 10.1007/s10753-011-9379-4.
74. Chen Y., Kijlstra A., Chen Y., Yang P. IL-17A stimulates the production of inflammatory mediators via Erk1/2, p38 MAPK, PI3K/Akt, and NF-κB pathways in ARPE-19 cells. Mol. Vis. 2011, 17:3072-3077. (http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3233389&tool=pmcentrez&rendertype=abstract. Accessed February 26, 2015).
75. Kerur N., Hirano Y., Tarallo V., et al. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Investig. Ophthalmol. Vis. Sci. 2013, 54:7395-7401. 10.1167/iovs.13-12500.
76. Shi G., Chen S., Wandu W.S., et al. Inflammasomes induced by 7-ketocholesterol and other stimuli in RPE and in bone marrow-derived cells differ markedly in production of IL-1β and IL-18. Invest. Ophthalmol. Vis. Sci. 2015, 10.1167/iovs.14-14557.
77. Kauppinen A., Niskanen H., Suuronen T., Kinnunen K., Salminen A., Kaarniranta K. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD). Immunol. Lett. 2012, 147(1-2):29-33. 10.1016/j.imlet.2012.05.005.
78. Tseng W.A., Thein T., Kinnunen K., et al. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2013, 54:110-120. 10.1167/iovs.12-10655.
79. Anderson O.A., Finkelstein A., Shima D.T. A2E induces IL-1ß production in retinal pigment epithelial cells via the NLRP3 inflammasome. PLoS One 2013, 8(6). 10.1371/journal.pone.0067263.
80. Piippo N., Korkmaz A., Hytti M., et al. Decline in cellular clearance systems induces inflammasome signaling in human ARPE-19 cells. Biochim. Biophys. Acta 2014, 1843(12):3038-3046. 10.1016/j.bbamcr.2014.09.015.
81. Hu Y., Lin H., Dib B., et al. Cholesterol Crystals Induce Inflammatory Cytokines Expression in a Human Retinal Pigment Epithelium Cell Line by Activating the NF-kappaB Pathway. Discov Med. 2014, 18(97):7-14. http://www.discoverymedicine.com/Yijun-Hu/2014/07/cholesterol-crystals-induce-inflammatory-cytokines-expression-in-arpe-19-cells-by-activating-the-nf-kappab-pathway/. Accessed February 26, 2015.
82. Darzynkiewicz Z., Pozarowski P. All that glitters is not gold: all that FLICA binds is not caspase. A caution in data interpretation-and new opportunities. Cytometry A 2007, 71(8):536-537. 10.1002/cyto.a.20425.
83. Xu H., Chen M., Forrester J.V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 2009, 28(5):348-368. 10.1016/j.preteyeres.2009.06.001.
84. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454(7203):428-435. 10.1038/nature07201.